{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:16:32Z","timestamp":1791656192019,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12325-025-03337-x","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T06:09:38Z","timestamp":1756447778000},"page":"5300-5312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Emerging Concepts in Diagnosis, Pathologic Features, and Treatment of Limbic-Predominant Amnestic Neurodegenerative Syndrome (LANS): A Narrative Review"],"prefix":"10.1007","volume":"42","author":[{"given":"Macie A.","family":"Serio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew R.","family":"Dethloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya L.","family":"Beesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"3337_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2023.09.008","volume":"40","author":"LX Tay","year":"2024","unstructured":"Tay LX, Ong SC, Tay LJ, Ng T, Parumasivam T. Economic burden of Alzheimer\u2019s disease: a systematic review. Value Health Reg Issues. 2024;40:1\u201312. https:\/\/doi.org\/10.1016\/j.vhri.2023.09.008.","journal-title":"Value Health Reg Issues"},{"issue":"3","key":"3337_CR2","first-page":"199","volume":"23","author":"T Esch","year":"2002","unstructured":"Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett. 2002;23(3):199\u2013208.","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"3337_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40142-018-0133-1","volume":"6","author":"N Jain","year":"2018","unstructured":"Jain N, Chen-Plotkin AS. Genetic modifiers in neurodegeneration. Curr Genet Med Rep. 2018;6(1):11\u20139. https:\/\/doi.org\/10.1007\/s40142-018-0133-1.","journal-title":"Curr Genet Med Rep"},{"issue":"10","key":"3337_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","volume":"6","author":"YL Gao","year":"2018","unstructured":"Gao YL, Wang N, Sun FR, Cao XP, Zhang W, Yu JT. Tau in neurodegenerative disease. Ann Transl Med. 2018;6(10):175. https:\/\/doi.org\/10.21037\/atm.2018.04.23.","journal-title":"Ann Transl Med"},{"key":"3337_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00839-8","author":"EA Kellett","year":"2025","unstructured":"Kellett EA, Bademosi AT, Walker AK. Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration. Mol Neurodegener. 2025. https:\/\/doi.org\/10.1186\/s13024-025-00839-8.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"3337_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/0019-5545.33264","volume":"49","author":"V Rajmohan","year":"2007","unstructured":"Rajmohan V, Mohandas E. The limbic system. Indian J Psychiatry. 2007;49(2):132. https:\/\/doi.org\/10.4103\/0019-5545.33264.","journal-title":"Indian J Psychiatry"},{"issue":"7","key":"3337_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"key":"3337_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M. Clinical aspects of Alzheimer\u2019s disease. Clin Biochem. 2019;72:3\u20136. https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.04.015.","journal-title":"Clin Biochem"},{"issue":"1","key":"3337_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14202","volume":"21","author":"DA Wolk","year":"2025","unstructured":"Wolk DA, Nelson PT, Apostolova L, et al. Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. Alzheimers Dement. 2025;21(1): e14202. https:\/\/doi.org\/10.1002\/alz.14202.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"3337_CR10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1017\/S1355617706060267","volume":"12","author":"HR Griffith","year":"2006","unstructured":"Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC. Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc. 2006;12(2):166\u201375. https:\/\/doi.org\/10.1017\/S1355617706060267.","journal-title":"J Int Neuropsychol Soc"},{"key":"3337_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-psych-113011-143733","volume":"67","author":"M Moscovitch","year":"2016","unstructured":"Moscovitch M, Cabeza R, Winocur G, Nadel L. Episodic memory and beyond: the Hippocampus and Neocortex in transformation. Annu Rev Psychol. 2016;67:105. https:\/\/doi.org\/10.1146\/annurev-psych-113011-143733.","journal-title":"Annu Rev Psychol"},{"issue":"11","key":"3337_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tics.2011.10.001","volume":"15","author":"JR Binder","year":"2011","unstructured":"Binder JR, Desai RH. The neurobiology of semantic memory. Trends Cogn Sci. 2011;15(11):527. https:\/\/doi.org\/10.1016\/j.tics.2011.10.001.","journal-title":"Trends Cogn Sci"},{"issue":"11","key":"3337_CR13","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3174\/ajnr.A4059","volume":"35","author":"FD Raslau","year":"2014","unstructured":"Raslau FD, Klein AP, Ulmer JL, Mathews V, Mark LP. Memory part 1: overview. AJNR Am J Neuroradiol. 2014;35(11):2058. https:\/\/doi.org\/10.3174\/ajnr.A4059.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3337_CR14","doi-asserted-by":"publisher","unstructured":"Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy | Neurology. Accessed Nov 15, 2024. https:\/\/doi.org\/10.1212\/WNL.0000000000207159","DOI":"10.1212\/WNL.0000000000207159"},{"issue":"1","key":"3337_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","volume":"144","author":"PT Nelson","year":"2022","unstructured":"Nelson PT, Brayne C, Flanagan ME, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022;144(1):27\u201344. https:\/\/doi.org\/10.1007\/s00401-022-02444-1.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3337_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.2610-10.2011","volume":"31","author":"OA Shipton","year":"2011","unstructured":"Shipton OA, Leitz JR, Dworzak J, et al. Tau protein is required for amyloid \u03b2-induced impairment of hippocampal long-term potentiation. J Neurosci. 2011;31(5):1688\u201392. https:\/\/doi.org\/10.1523\/JNEUROSCI.2610-10.2011.","journal-title":"J Neurosci"},{"issue":"11","key":"3337_CR17","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","volume":"29","author":"EK Pickett","year":"2019","unstructured":"Pickett EK, Herrmann AG, McQueen J, et al. Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s disease. Cell Rep. 2019;29(11):3592-3604.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.11.044.","journal-title":"Cell Rep"},{"issue":"3","key":"3337_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-2002-4309","volume":"4","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid \u03b2-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer\u2019s disease brain exists. J Alzheimers Dis. 2002;4(3):193\u2013201. https:\/\/doi.org\/10.3233\/JAD-2002-4309.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"3337_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23(3):1851. https:\/\/doi.org\/10.3390\/ijms23031851.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3337_CR20","first-page":"1062","volume":"5","author":"S Akhondzadeh","year":"2002","unstructured":"Akhondzadeh S, Noroozian M. Alzheimer\u2019s disease: pathophysiology and pharmacotherapy. IDrugs. 2002;5(11):1062\u20139.","journal-title":"IDrugs"},{"issue":"6","key":"3337_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327. https:\/\/doi.org\/10.1093\/brain\/awz099.","journal-title":"Brain"},{"issue":"1","key":"3337_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-021-02383-3","volume":"143","author":"MT Uemura","year":"2022","unstructured":"Uemura MT, Robinson JL, Cousins KAQ, et al. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathol. 2022;143(1):15\u201331. https:\/\/doi.org\/10.1007\/s00401-021-02383-3.","journal-title":"Acta Neuropathol"},{"key":"3337_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25. https:\/\/doi.org\/10.3389\/fnmol.2019.00025.","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"3337_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae183","volume":"6","author":"N Corriveau-Lecavalier","year":"2024","unstructured":"Corriveau-Lecavalier N, Botha H, Graff-Radford J, et al. Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome. Brain Commun. 2024;6(4): fcae183. https:\/\/doi.org\/10.1093\/braincomms\/fcae183.","journal-title":"Brain Commun"},{"issue":"12","key":"3337_CR25","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1093\/brain\/awaa315","volume":"143","author":"KY Liu","year":"2020","unstructured":"Liu KY, Reeves S, McAleese KE, et al. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer\u2019s disease. Brain. 2020;143(12):3842\u20139. https:\/\/doi.org\/10.1093\/brain\/awaa315.","journal-title":"Brain"},{"issue":"5796","key":"3337_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133. https:\/\/doi.org\/10.1126\/science.1134108.","journal-title":"Science"},{"issue":"7","key":"3337_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/jnen\/nlab050","volume":"80","author":"PT Nelson","year":"2021","unstructured":"Nelson PT. LATE neuropathologic changes with little or no Alzheimer disease is common and is associated with cognitive impairment but not frontotemporal dementia. J Neuropathol Exp Neurol. 2021;80(7):649\u201351. https:\/\/doi.org\/10.1093\/jnen\/nlab050.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"3337_CR28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1001\/jamaneurol.2013.3961","volume":"70","author":"RS Wilson","year":"2013","unstructured":"Wilson RS, Yu L, Trojanowski JQ, et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013;70(11):1418\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2013.3961.","journal-title":"JAMA Neurol"},{"issue":"1","key":"3337_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1):74\u201383. https:\/\/doi.org\/10.1002\/ana.25123.","journal-title":"Ann Neurol"},{"issue":"14","key":"3337_CR30","doi-asserted-by":"publisher","first-page":"e1951","DOI":"10.1212\/WNL.0000000000010454","volume":"95","author":"A Kapasi","year":"2020","unstructured":"Kapasi A, Yu L, Boyle PA, Barnes LL, Bennett DA, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020;95(14):e1951\u201362. https:\/\/doi.org\/10.1212\/WNL.0000000000010454.","journal-title":"Neurology"},{"key":"3337_CR31","doi-asserted-by":"publisher","unstructured":"Neocortical\u2010type Lewy bodies and limbic\u2010predominant age\u2010related TDP\u201043 encephalopathy neuropathologic change in community\u2010dwelling older persons - Agrawal - 2020 - Alzheimer\u2019s & Dementia - Wiley Online Library. Accessed Nov 18, 2024. https:\/\/doi.org\/10.1002\/alz.047449","DOI":"10.1002\/alz.047449"},{"issue":"4","key":"3337_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00401-006-0043-2","volume":"111","author":"ZT Ding","year":"2006","unstructured":"Ding ZT, Wang Y, Jiang YP, et al. Argyrophilic grain disease: frequency and neuropathology in centenarians. Acta Neuropathol. 2006;111(4):320\u20138. https:\/\/doi.org\/10.1007\/s00401-006-0043-2.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3337_CR33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Whitwell JL, Weigand SD, et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 2014;127(6):811\u201324. https:\/\/doi.org\/10.1007\/s00401-014-1269-z.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"3337_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10(9):785\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(11)70156-9.","journal-title":"Lancet Neurol"},{"key":"3337_CR35","doi-asserted-by":"crossref","unstructured":"Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated | Brain | Oxford Academic. Accessed Nov 18, 2024. https:\/\/academic.oup.com\/brain\/article\/146\/6\/2557\/7067885","DOI":"10.1093\/brain\/awad059"},{"issue":"4","key":"3337_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3233\/JAD-191040","volume":"73","author":"M Buciuc","year":"2020","unstructured":"Buciuc M, Wennberg AM, Weigand SD, et al. Effect modifiers of TDP-43-associated hippocampal atrophy rates in patients with Alzheimer\u2019s disease neuropathological changes. J Alzheimers Dis. 2020;73(4):1511. https:\/\/doi.org\/10.3233\/JAD-191040.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"3337_CR37","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12763","volume":"19","author":"MJ Grothe","year":"2023","unstructured":"Grothe MJ, Moscoso A, Silva-Rodr\u00edguez J, Lange C, Nho K, Saykin AJ, Nelson PT, Sch\u00f6ll M, Buchert R, Teipel S, Alzheimer\u2019s Disease Neuroimaging Initiative. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement. 2023;19(4):1234\u201344. https:\/\/doi.org\/10.1002\/alz.12763","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3337_CR38","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/brain\/awy049","volume":"141","author":"H Botha","year":"2018","unstructured":"Botha H, Mantyh WG, Murray ME, et al. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain. 2018;141(4):1201\u201317. https:\/\/doi.org\/10.1093\/brain\/awy049.","journal-title":"Brain"},{"issue":"5","key":"3337_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/alz.12241","volume":"17","author":"DC Woodworth","year":"2020","unstructured":"Woodworth DC, Nguyen HL, Khan Z, Kawas CH, Corrada MM, Sajjadi SA. Utility of MRI in the identification of hippocampal sclerosis of aging. Alzheimers Dement. 2020;17(5):847. https:\/\/doi.org\/10.1002\/alz.12241.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3337_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE. Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(4): a006213. https:\/\/doi.org\/10.1101\/cshperspect.a006213.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"3337_CR41","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1212\/WNL.0000000000009722","volume":"95","author":"M Buciuc","year":"2020","unstructured":"Buciuc M, Botha H, Murray ME, et al. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology. 2020;95(1):e23\u201334. https:\/\/doi.org\/10.1212\/WNL.0000000000009722.","journal-title":"Neurology"},{"issue":"8","key":"3337_CR42","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association workgroup. Alzheimers Dement. 2024;20(8):5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3337_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12779\/dnd.2023.22.1.16","volume":"22","author":"SH Park","year":"2023","unstructured":"Park SH, Kwon KJ, Kim MY, et al. Diagnostic tools for Alzheimer\u2019s disease: a narrative review based on our own research experience. Dement Neurocogn Disord. 2023;22(1):16\u201327. https:\/\/doi.org\/10.12779\/dnd.2023.22.1.16.","journal-title":"Dement Neurocogn Disord"},{"key":"3337_CR44","unstructured":"Fluid Biomarkers in Dementia Diagnosis: CONTINUUM: Lifelong Learning in Neurology. Accessed Nov 12, 2024. https:\/\/journals.lww.com\/continuum\/fulltext\/2022\/06000\/fluid_biomarkers_in_dementia_diagnosis.11.aspx"},{"issue":"8","key":"3337_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081367","volume":"11","author":"A Varesi","year":"2022","unstructured":"Varesi A, Carrara A, Pires VG, et al. Blood-based biomarkers for Alzheimer\u2019s disease diagnosis and progression: an overview. Cells. 2022;11(8): 1367. https:\/\/doi.org\/10.3390\/cells11081367.","journal-title":"Cells"},{"key":"3337_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02671-0","author":"M Chung","year":"2024","unstructured":"Chung M, Carter EK, Veire AM, et al. Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains. Acta Neuropathol. 2024. https:\/\/doi.org\/10.1007\/s00401-023-02671-0.","journal-title":"Acta Neuropathol"},{"issue":"7899","key":"3337_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, et al. TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature. 2022;603(7899):124\u201330. https:\/\/doi.org\/10.1038\/s41586-022-04424-7.","journal-title":"Nature"},{"issue":"4","key":"3337_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"R Clifford","year":"2018","unstructured":"Clifford R, Jack J, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2018;14(4):535. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"6","key":"3337_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1.","journal-title":"Lancet Neurol"},{"issue":"8","key":"3337_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080688","volume":"11","author":"A Carotenuto","year":"2021","unstructured":"Carotenuto A, Traini E, Fasanaro AM, Battineni G, Amenta F. Tele-neuropsychological assessment of Alzheimer\u2019s disease. J Pers Med. 2021;11(8): 688. https:\/\/doi.org\/10.3390\/jpm11080688.","journal-title":"J Pers Med"},{"issue":"1","key":"3337_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14010113","volume":"14","author":"I Veneziani","year":"2024","unstructured":"Veneziani I, Marra A, Formica C, et al. Applications of artificial intelligence in the neuropsychological assessment of dementia: a systematic review. J Pers Med. 2024;14(1): 113. https:\/\/doi.org\/10.3390\/jpm14010113.","journal-title":"J Pers Med"},{"issue":"11","key":"3337_CR52","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease. Curr Neuropharmacol. 2020;18(11):1106\u201325. https:\/\/doi.org\/10.2174\/1570159X18666200528142429.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"3337_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J. Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimers Res Ther. 2023;15(1): 175. https:\/\/doi.org\/10.1186\/s13195-023-01314-6.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"3337_CR54","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.36922\/an.2603","volume":"3","author":"M Altuna","year":"2024","unstructured":"Altuna M. Limbic-predominant age-related TDP-43 encephalopathy: Amnestic-predominant cognitive decline beyond Alzheimer\u2019s disease. Adv Neurol. 2024;3(2):2603. https:\/\/doi.org\/10.36922\/an.2603.","journal-title":"Adv Neurol"},{"issue":"2","key":"3337_CR55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-201166","volume":"80","author":"M Buciuc","year":"2021","unstructured":"Buciuc M, Tosakulwong N, Machulda MM, et al. TAR DNA-binding protein 43 is associated with rate of memory, functional and global cognitive decline in the decade prior to death. J Alzheimers Dis. 2021;80(2):683. https:\/\/doi.org\/10.3233\/JAD-201166.","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"3337_CR56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","volume":"43","author":"H Rhinn","year":"2022","unstructured":"Rhinn H, Tatton N, McCaughey S, Kurnellas M, Rosenthal A. Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol Sci. 2022;43(8):641\u201352. https:\/\/doi.org\/10.1016\/j.tips.2021.11.015.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"3337_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11910-022-01232-4","volume":"22","author":"MT Duong","year":"2022","unstructured":"Duong MT, Wolk DA. Limbic-predominant age-related TDP-43 encephalopathy: LATE-breaking updates in clinicopathologic features and biomarkers. Curr Neurol Neurosci Rep. 2022;22(11):689\u201398. https:\/\/doi.org\/10.1007\/s11910-022-01232-4.","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03337-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:02:34Z","timestamp":1762030954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03337-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3337"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03337-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alan D Kaye is an Editorial Board member of Advances in Therapy. Alan D Kaye was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. Sahar Shekoohi, Macie A. Serio, Drew R. Dethloff, Grant C. Curry, and Maya L. Beesley have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and contains no new studies with human participants or animals performed by any authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}